BriaCell Therapeutics Corp.
BCTXW · NASDAQ
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$26,556 | -$4,932 | -$20,302 | -$26,839 |
| Dep. & Amort. | $107 | $84 | $15 | $15 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $777 | $1,804 | $2,194 | $3,075 |
| Change in WC | -$1,920 | $7,053 | -$3,532 | -$391 |
| Other Non-Cash | -$578 | -$28,136 | -$2,120 | $11,656 |
| Operating Cash Flow | -$28,171 | -$24,126 | -$23,745 | -$12,484 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$457 | $0 | $0 |
| Net Acquisitions | $0 | -$225 | $0 | $0 |
| Inv. Purchases | -$7,316 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$330 | $0 | $0 | $0 |
| Investing Cash Flow | -$7,646 | -$682 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $45,751 | $4,419 | $4,000 | $0 |
| Stock Repurch. | $0 | $0 | -$47 | -$13,025 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$303 | $0 | $2 | $6,429 |
| Financing Cash Flow | $45,448 | $4,419 | $3,954 | -$3,743 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $9,632 | -$20,389 | -$19,791 | -$16,227 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $862 | $21,251 | $41,042 | $57,269 |
| End Cash | $10,494 | $862 | $21,251 | $41,042 |
| Free Cash Flow | -$28,171 | -$24,583 | -$23,745 | -$12,484 |